These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7808338)

  • 1. Antioxidant activity of calcium channel blocking drugs.
    Mak IT; Weglicki WB
    Methods Enzymol; 1994; 234():620-30. PubMed ID: 7808338
    [No Abstract]   [Full Text] [Related]  

  • 2. Antioxidant effects of calcium channel blockers against free radical injury in endothelial cells. Correlation of protection with preservation of glutathione levels.
    Mak IT; Boehme P; Weglicki WB
    Circ Res; 1992 Jun; 70(6):1099-103. PubMed ID: 1576732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antioxidant effects of calcium antagonists on rat myocardial membrane lipid peroxidation.
    Sugawara H; Tobise K; Kikuchi K
    Hypertens Res; 1996 Dec; 19(4):223-8. PubMed ID: 8986452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of dihydropyridine Ca-blockers against endothelial cell oxidative injury due to combined nitric oxide and superoxide.
    Mak IT; Zhang J; Weglicki WB
    Pharmacol Res; 2002 Jan; 45(1):27-33. PubMed ID: 11820858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential actions of calcium antagonists on calcium binding to cardiac sarcolemma.
    Pang DC; Sperelakis N
    Eur J Pharmacol; 1982 Jul; 81(3):403-9. PubMed ID: 6981516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against ischaemic ventricular fibrillation by blocking agents of myocardial cell calcium influx. Electrophysiological study in the pig in situ heart.
    Timour Q; Larbre JP; Aupetit JF; Gerentes-Chassagne I; Loufoua-Moundanga J; Kioueh I; Faucon G
    Fundam Clin Pharmacol; 1991; 5(7):641-4. PubMed ID: 1778542
    [No Abstract]   [Full Text] [Related]  

  • 7. Protection by Ca2+ channel blockers (nifedipine, diltiazem and verapamil) against the toxicity of oxidized low density lipoprotein to cultured lymphoid cells.
    Nègre-Salvayre A; Salvayre R
    Br J Pharmacol; 1992 Nov; 107(3):738-44. PubMed ID: 1472971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of calcium channel blockers against free radical-impaired endothelial cell proliferation.
    Mak IT; Boehme P; Weglicki WB
    Biochem Pharmacol; 1995 Oct; 50(9):1531-4. PubMed ID: 7503807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of nifedipine, verapamil, and diltiazem on [3H]-nitrendipine binding to the purified canine cardiac sarcolemmal membrane.
    Kurobe Y; Ishii K; Kano T; Ando J
    Bull Osaka Med Sch; 1985 Jul; 31(1):1-14. PubMed ID: 3026536
    [No Abstract]   [Full Text] [Related]  

  • 10. Antioxidant and cytoprotective activities of the calcium channel blocker mibefradil.
    Mason RP; Mak IT; Walter MF; Tulenko TN; Mason PE
    Biochem Pharmacol; 1998 Jun; 55(11):1843-52. PubMed ID: 9714303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
    Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
    Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential cardiovascular effects of calcium channel blocking agents: potential mechanisms.
    Millard RW; Lathrop DA; Grupp G; Ashraf M; Grupp IL; Schwartz A
    Am J Cardiol; 1982 Feb; 49(3):499-506. PubMed ID: 6277175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative antioxidant activities of propranolol, nifedipine, verapamil, and diltiazem against sarcolemmal membrane lipid peroxidation.
    Mak IT; Weglicki WB
    Circ Res; 1990 May; 66(5):1449-52. PubMed ID: 2335037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitor effects of diltiazem, nicardipine, nifedipine and verapamil on the norepinephrine-induced contractions of the canine saphenous vein in calcium-free medium.
    Saïag B; Milon D; Bentue-Ferrer D; Allain H; Rault B; Van den Driessche J
    Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):255-69. PubMed ID: 8008975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Myocardial cellular mechanism of action of calcium antagonists].
    Ferrari R; Boffa GM; Ciampalini G; Ceconi C
    Cardiologia; 1985 Feb; 30(2):77-89. PubMed ID: 3905004
    [No Abstract]   [Full Text] [Related]  

  • 16. Tissue response selectivity of calcium antagonists is not due to heterogeneity of [3H]-nitrendipine binding sites.
    Bristow MR; Ginsburg R; Laser JA; McAuley BJ; Minobe W
    Br J Pharmacol; 1984 Jun; 82(2):309-20. PubMed ID: 6329392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Class IV Ca2+ antagonists do not affect lipid peroxidation in singlet oxygen challenged cardiomyocytes.
    Ver Donck L; Verellen G; Vandewiele R; De Clerck F; Borgers M
    Cell Biol Int Rep; 1990 Apr; 14(4):399-406. PubMed ID: 2354524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of multiple administration of calcium antagonists on lipid peroxidation in rat liver microsomes.
    Koleva M; Alov P
    Gen Pharmacol; 1996 Jul; 27(5):891-3. PubMed ID: 8842695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid peroxidation is another potential mechanism besides pore-formation underlying hemolysis of tentacle extract from the jellyfish Cyanea capillata.
    Wang T; Wen XJ; Mei XB; Wang QQ; He Q; Zheng JM; Zhao J; Xiao L; Zhang LM
    Mar Drugs; 2013 Jan; 11(1):67-80. PubMed ID: 23303301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of four calcium channel blockers on central cardiovascular control.
    Montastruc JL; Damase-Michel C; Dang-Tran L; Montastruc P
    Arch Int Pharmacodyn Ther; 1989; 297():112-9. PubMed ID: 2730230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.